Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab in Chinese Patients with Ankylosing Spondylitis
NCT01248793Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2010
- Primary completion
- May 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of golimumab in ankylosing spondylitis (AS), sponsored by Janssen Pharmaceutical. Started Oct 2010; status: completed.
02
Drugs
golimumab
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT01248793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01248793.